(-)-gallocatechin gallate has been researched along with sinefungin in 2 studies
| Studies ((-)-gallocatechin gallate) | Trials ((-)-gallocatechin gallate) | Recent Studies (post-2010) ((-)-gallocatechin gallate) | Studies (sinefungin) | Trials (sinefungin) | Recent Studies (post-2010) (sinefungin) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 198 | 0 | 57 |
| Protein | Taxonomy | (-)-gallocatechin gallate (IC50) | sinefungin (IC50) |
|---|---|---|---|
| NS5 | Zika virus | 1.4 | |
| Protein arginine N-methyltransferase 5 | Homo sapiens (human) | 8.6 | |
| mRNA cap guanine-N7 methyltransferase | Homo sapiens (human) | 0.0335 | |
| Indolethylamine N-methyltransferase | Homo sapiens (human) | 4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.319 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.3072 | |
| Nicotinamide N-methyltransferase | Homo sapiens (human) | 5.2 | |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | 2.5 | |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 0.1 | |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 1 | |
| RNA guanine-N7 methyltransferase activating subunit | Homo sapiens (human) | 0.319 | |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | 0.1 | |
| Non-structural protein 1 | Dengue virus | 0.041 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Anderson, L; Bassi, ÊJ; Cardoso, SH; da Silva Santos-Júnior, PF; da Silva-Júnior, EF; de Andrade Brandão, J; Silva, LR; Xavier de Araújo-Júnior, J | 1 |
2 review(s) available for (-)-gallocatechin gallate and sinefungin
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Druggable targets from coronaviruses for designing new antiviral drugs.
Topics: Animals; Antiviral Agents; Drug Design; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2 | 2020 |